Sperogenix Therapeutics is a platform company focused on developing and bringing to market rare disease therapeutics in China. Established in 2019, Sperogenix concentrates on mid-to-late clinical stage and commercial stage products across specific therapeutic areas: Pulmonary Vascular Disorders, Neurological Disorders, Inherited Metabolic Diseases, and Non-oncology Hematology Disorders. The company is committed to pioneering a...
Sperogenix Therapeutics is a platform company focused on developing and bringing to market rare disease therapeutics in China. Established in 2019, Sperogenix concentrates on mid-to-late clinical stage and commercial stage products across specific therapeutic areas: Pulmonary Vascular Disorders, Neurological Disorders, Inherited Metabolic Diseases, and Non-oncology Hematology Disorders. The company is committed to pioneering an innovative commercial model tailored for the rare disease sector in China, aiming to deliver affordable and reliable products and services to Chinese physicians and patients.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.